Thermo Fisher releases new IVD system

By staff writers

November 10, 2021 -- Thermo Fisher Scientific has released a new IVD system called Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR. The system is designed to support the development of assay menus and IVD testing.

The system allows users to broaden their assay options with interchangeable 96-well and 384-well blocks and features set run, analysis, and report settings to decrease operator errors. It also includes remote desktop and touchscreen controls, facial authentication, and voice command, the company said.

The Applied Biosystems QuantStudio 7 Pro Dx real-time PCR system is a new in vivo IVD system from Thermo Fisher that will enable assay developers and clinical testing laboratories to expand their assay menus and IVD testing capabilities. Image courtesy of Thermo Fisher.
Thermo Fisher highlights new spectrometry, chromatography
Thermo Fisher Scientific is highlighting new mass spectrometry and chromatography instruments and software at the American Society for Mass Spectrometry...
Thermo Fisher touts product launches at AACC 2021
Thermo Fisher Scientific is highlighting a variety of new products the company is launching at this week's American Association for Clinical Chemistry...
Thermo Fisher, AstraZeneca to develop NGS companion diagnostics
Thermo Fisher Scientific and AstraZeneca plan to co-develop companion diagnostics based on next-generation sequencing (NGS) to support targeted therapies.
Thermo Fisher secures EUA for 2 new COVID-19 tests
The U.S. Food and Drug Administration has granted emergency use authorization (EUA) to Thermo Fisher Scientific for two new COVID-19 tests, TaqPath COVID-19...
Thermo Fisher announces new suite of assays
Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells...

Copyright © 2021

Last Updated ls 11/10/2021 12:56:50 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current